Novel specific activity-based probes validate KLK proteases as druggable targets

  • Cancer Biol Ther. 2022 Dec 31;23(1):401-403. doi: 10.1080/15384047.2022.2074775.
Georgia Sotiropoulou  1 ,  Eleni Zingkou  1 ,  Georgios Pampalakis  2
Affiliations
  • 1. Department of Pharmacy, School of Health Sciences, University of Patras, Rion-Patras, Greece.
  • 2. Department of Pharmacology-Pharmacognosy, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece.
PMID: 35652924 DOI: 10.1080/15384047.2022.2074775
Keywords
ABPs; KLK proteolytic cascades; KLK-ABPs; KLKs; activity-based probes; activography; kallikrein-related peptidases; theranostic ABPs.